P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844944.65720.85 |
_version_ | 1827336896909410304 |
---|---|
author | J. McCloskey V. Pullarkat G. Mannis T. L. Lin S. A. Strickland A. T. Fathi H. P. Erba S. Faderl D. Chakravarthy Y. Lutska V. Chandrasekaran R. S. Cheung M. Levis |
author_facet | J. McCloskey V. Pullarkat G. Mannis T. L. Lin S. A. Strickland A. T. Fathi H. P. Erba S. Faderl D. Chakravarthy Y. Lutska V. Chandrasekaran R. S. Cheung M. Levis |
author_sort | J. McCloskey |
collection | DOAJ |
first_indexed | 2024-03-07T18:41:08Z |
format | Article |
id | doaj.art-07df082019d54b7f99a42864456223eb |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T18:41:08Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-07df082019d54b7f99a42864456223eb2024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01641341410.1097/01.HS9.0000844944.65720.85202206003-00413P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIAJ. McCloskey0V. Pullarkat1G. Mannis2T. L. Lin3S. A. Strickland4A. T. Fathi5H. P. Erba6S. Faderl7D. Chakravarthy8Y. Lutska9V. Chandrasekaran10R. S. Cheung11M. Levis121 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ2 City of Hope Comprehensive Cancer Center, Duarte, CA3 Stanford University Medical Center, Palo Alto, CA4 University of Kansas Medical Center, Kansas City, KS5 Vanderbilt-Ingram Cancer Center, Nashville, TN6 Massachusetts General Hospital Cancer Center/Harvard Medical School, Boston, MA7 Duke University School of Medicine, Durham, NC8 Jazz Pharmaceuticals, Palo Alto, CA8 Jazz Pharmaceuticals, Palo Alto, CA9 Jazz Pharmaceuticals, Philadelphia, PA9 Jazz Pharmaceuticals, Philadelphia, PA8 Jazz Pharmaceuticals, Palo Alto, CA10 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844944.65720.85 |
spellingShingle | J. McCloskey V. Pullarkat G. Mannis T. L. Lin S. A. Strickland A. T. Fathi H. P. Erba S. Faderl D. Chakravarthy Y. Lutska V. Chandrasekaran R. S. Cheung M. Levis P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA HemaSphere |
title | P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
title_full | P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
title_fullStr | P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
title_full_unstemmed | P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
title_short | P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA |
title_sort | p514 v fast master trial preliminary results of treatment with cpx 351 plus midostaurin in adults with newly diagnosed flt3 mutated acute myeloid leukemia |
url | http://journals.lww.com/10.1097/01.HS9.0000844944.65720.85 |
work_keys_str_mv | AT jmccloskey p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT vpullarkat p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT gmannis p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT tllin p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT sastrickland p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT atfathi p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT hperba p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT sfaderl p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT dchakravarthy p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT ylutska p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT vchandrasekaran p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT rscheung p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia AT mlevis p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia |